In CML, auto-phosphorylation of tyrosine 177 on BCR-ABL fusion protein provides a docking site for the adapter molecule, growth factor receptor-bound protein 2 (GRB-2) [34]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.